TR199801608T2 - Klopidogrel ve bir tromboz önleyici içeren karisimlar - Google Patents

Klopidogrel ve bir tromboz önleyici içeren karisimlar

Info

Publication number
TR199801608T2
TR199801608T2 TR1998/01608T TR9801608T TR199801608T2 TR 199801608 T2 TR199801608 T2 TR 199801608T2 TR 1998/01608 T TR1998/01608 T TR 1998/01608T TR 9801608 T TR9801608 T TR 9801608T TR 199801608 T2 TR199801608 T2 TR 199801608T2
Authority
TR
Turkey
Prior art keywords
mixtures containing
containing clopidogrel
thrombosis inhibitor
clopidogrel
thrombosis
Prior art date
Application number
TR1998/01608T
Other languages
English (en)
Inventor
Bernat Andre
Herbert Jean-Marc
Savi Pierre
Original Assignee
Sanofi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9489354&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TR199801608(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sanofi filed Critical Sanofi
Publication of TR199801608T2 publication Critical patent/TR199801608T2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/618—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate
    • A61K31/621—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate having the hydroxy group in position 2 esterified, e.g. benorylate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/36—Antigestagens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/44—Glucocorticosteroids; Drugs increasing or potentiating the activity of glucocorticosteroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Abstract

Bulus, bir etkin maddeler karisimi içeren bir ilaç bilesimi ile ilgilidir; sözkonusu karisimda, etkin maddeler klopidogrel ve aspirindir ve bu iki bilesen, serbest halde ya da ilaç sanayiinde kullanilmaya uygun bir tuz biçiminde bulunur
TR1998/01608T 1996-02-19 1997-02-17 Klopidogrel ve bir tromboz önleyici içeren karisimlar TR199801608T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9602027A FR2744918B1 (fr) 1996-02-19 1996-02-19 Nouvelles associations de principes actifs contenant un derive de thieno(3,2-c)pyridine et un antithrombotique

Publications (1)

Publication Number Publication Date
TR199801608T2 true TR199801608T2 (tr) 1998-11-23

Family

ID=9489354

Family Applications (1)

Application Number Title Priority Date Filing Date
TR1998/01608T TR199801608T2 (tr) 1996-02-19 1997-02-17 Klopidogrel ve bir tromboz önleyici içeren karisimlar

Country Status (29)

Country Link
US (1) US5989578A (tr)
EP (1) EP0881901B1 (tr)
JP (1) JP3662028B2 (tr)
KR (1) KR100295345B1 (tr)
CN (1) CN1116042C (tr)
AT (1) ATE218870T1 (tr)
AU (1) AU715655B2 (tr)
BR (1) BR9707556A (tr)
CA (1) CA2246289C (tr)
CZ (1) CZ292363B6 (tr)
DE (2) DE69713287T2 (tr)
DK (1) DK0881901T3 (tr)
EE (1) EE03513B1 (tr)
ES (1) ES2176684T3 (tr)
FR (1) FR2744918B1 (tr)
HK (1) HK1017850A1 (tr)
HU (1) HU225036B1 (tr)
IL (1) IL125848A (tr)
IS (1) IS1892B (tr)
NO (2) NO317747B3 (tr)
NZ (1) NZ331444A (tr)
PL (1) PL187292B1 (tr)
PT (1) PT881901E (tr)
RU (1) RU2184547C2 (tr)
SI (1) SI0881901T1 (tr)
SK (1) SK284285B6 (tr)
TR (1) TR199801608T2 (tr)
UA (1) UA51695C2 (tr)
WO (1) WO1997029753A1 (tr)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2322824A1 (en) * 1998-03-13 1999-09-16 Merck & Co., Inc. Combination therapy and composition for acute coronary ischemic syndrome and related conditions
WO1999065500A1 (en) 1998-06-17 1999-12-23 Bristol-Myers Squibb Company Preventing cerebral infarction through administration of adp-receptor antiplatelet and antihypertensive drugs in combination
US6509348B1 (en) 1998-11-03 2003-01-21 Bristol-Myers Squibb Company Combination of an ADP-receptor blocking antiplatelet drug and a thromboxane A2 receptor antagonist and a method for inhibiting thrombus formation employing such combination
FR2792836B3 (fr) 1999-04-30 2001-07-27 Sanofi Sa Composition pharmaceutique sous forme unitaire contenant de l'aspirine et de l'hydrogenosulfate de clopidogrel
FR2797400A1 (fr) * 1999-08-11 2001-02-16 Sanofi Synthelabo Associations a activite anti-thrombotique constituees de l'hydrogenosulfate de clopidogrel et d'un antagoniste des recepteurs gpiib/iiia et les compositions pharmaceutiques les contenant
PL206138B1 (pl) * 2000-12-25 2010-07-30 Daiichi Sankyo Company Limiteddaiichi Sankyo Company Limited Kompozycja farmaceutyczna zawierająca aspirynę oraz zestaw i zastosowanie składników kompozycji
SE0101932D0 (sv) * 2001-05-31 2001-05-31 Astrazeneca Ab Pharmaceutical combinations
FR2832929A1 (fr) * 2001-12-05 2003-06-06 Sanofi Synthelabo Compositions pharmaceutiques contenant un agent antithrombotique et un derive d'amines cycliques
AU2003270861A1 (en) * 2002-10-02 2004-04-23 Bristol-Myers Squibb Company Novel combination of a factor xa inhibitor and clopidogrel
US20070243632A1 (en) * 2003-07-08 2007-10-18 Coller Barry S Methods for measuring platelet reactivity of patients that have received drug eluting stents
ATE536889T1 (de) 2003-07-08 2011-12-15 Accumetrics Inc Kontrollierte thrombozyten-aktivierung zur überwachung der behandlung von adp-antagonisten
HUP0400982A2 (en) * 2004-05-17 2006-08-28 Chemor Kutato New veterinary product for honeybees
US20060222640A1 (en) * 2005-03-29 2006-10-05 Boehringer Ingelheim International Gmbh New pharmaceutical compositions for treatment of thrombosis
EP1926736A4 (en) * 2005-09-21 2010-08-25 Chong Kun Dang Pharm Corp NEW RESINATE COMPLEX OF S-CLOPIDOGREL AND METHOD FOR THE PRODUCTION THEREOF
WO2008048083A1 (es) * 2006-10-17 2008-04-24 Espinosa Abdala Leopoldo De Je Composiciones farmacéuticas para el tratamiento de enfermedades tromboembólicas
DE102006051625A1 (de) 2006-11-02 2008-05-08 Bayer Materialscience Ag Kombinationstherapie substituierter Oxazolidinone
KR20160033792A (ko) 2007-04-27 2016-03-28 사이덱스 파마슈티칼스, 인크. 클로피도그렐 및 설포알킬 에테르 사이클로덱스트린을 함유하는 제형 및 사용 방법
KR100949273B1 (ko) * 2008-02-22 2010-03-25 한올제약주식회사 복합제제
DE102008032361A1 (de) * 2008-07-10 2010-01-21 Csl Behring Gmbh Der Einsatz von Faktor VIII und vWF bzw. vWF-enthaltenden Konzentraten zur Therapie der durch Thrombocyten-Inhibitoren induzierte Koagulopathie
US8236782B2 (en) * 2009-05-13 2012-08-07 Cydex Pharmaceuticals, Inc. Pharmaceutical compositions comprising prasugrel and cyclodextrin derivatives and methods of making and using the same
EA021588B1 (ru) 2009-06-25 2015-07-30 Тетра Сиа Бетаиновые соли ацетилсалициловой кислоты
US8563574B2 (en) 2009-12-07 2013-10-22 Academic Pharmaceuticals, Inc. Parenteral formulation of clopidogrel
CN102389436A (zh) * 2011-09-09 2012-03-28 北京阜康仁生物制药科技有限公司 一种抗血小板聚集的药物组合物
KR101675501B1 (ko) * 2011-11-02 2016-11-14 한국유나이티드제약 주식회사 클로피도그렐 및 아스피린의 복합제제
US8513278B2 (en) 2011-11-26 2013-08-20 Academic Pharmaceuticals, Inc. Parenteral dextrose formulation of clopidogrel
CN102406938A (zh) * 2011-11-29 2012-04-11 北京阜康仁生物制药科技有限公司 一种抗血栓的药物组合物
WO2013133620A1 (en) * 2012-03-09 2013-09-12 Yuhan Corporation Pharmaceutical composition comprising clopidogrel and aspirin and process for preparing the same
CN103720700A (zh) * 2012-10-10 2014-04-16 江苏威凯尔医药科技有限公司 含有阿斯匹林和维卡格雷的药用组合物
EP2796145B1 (en) 2013-04-22 2017-11-01 CSL Ltd. A covalent complex of von willebrand factor and faktor viii linked by a disulphide bridge
KR101502588B1 (ko) 2013-05-01 2015-03-16 한국유나이티드제약 주식회사 클로피도그렐 및 아스피린의 복합제제
WO2015015062A1 (fr) * 2013-08-02 2015-02-05 Sanofi Comprime pharmaceutique comprenant de l'acide acetylsalicylique et du clopidogrel
HUP1400294A2 (hu) 2014-06-13 2015-12-28 Skillpharm Kft Clopidogrel új alkalmazása
CN107698620A (zh) * 2015-06-23 2018-02-16 江苏天士力帝益药业有限公司 一种氘代噻吩并哌啶衍生物、制备方法及其应用
RU2745774C1 (ru) * 2020-08-14 2021-03-31 Алексей Викторович Марочков Способ лечения пациентов с новой коронавирусной инфекцией (covid-19)
US20230059869A1 (en) 2021-08-03 2023-02-23 Liqmeds Worldwide Limited Oral pharmaceutical solution of clopidogrel

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2307538A1 (fr) * 1975-04-18 1976-11-12 Centre Etd Ind Pharma Nouveau medicament anti-agregant plaquettaire

Also Published As

Publication number Publication date
PL327923A1 (en) 1999-01-04
NO2010015I1 (no) 2010-07-26
CA2246289C (fr) 2003-12-16
US5989578A (en) 1999-11-23
HUP9901144A2 (hu) 1999-09-28
NO983812L (no) 1998-10-09
ATE218870T1 (de) 2002-06-15
FR2744918A1 (fr) 1997-08-22
HU225036B1 (en) 2006-05-29
NO317747B3 (no) 2011-10-03
JP3662028B2 (ja) 2005-06-22
PT881901E (pt) 2002-09-30
DE69713287D1 (de) 2002-07-18
CN1211922A (zh) 1999-03-24
SK284285B6 (sk) 2005-01-03
DE122010000030I1 (de) 2010-10-21
DE122010000030I2 (de) 2012-06-21
PL187292B1 (pl) 2004-06-30
NO2010015I2 (no) 2012-11-12
SK110598A3 (en) 1999-01-11
JPH11510818A (ja) 1999-09-21
IL125848A (en) 2000-11-21
CN1116042C (zh) 2003-07-30
FR2744918B1 (fr) 1998-05-07
WO1997029753A1 (fr) 1997-08-21
HUP9901144A3 (en) 2001-04-28
AU1884497A (en) 1997-09-02
KR100295345B1 (ko) 2001-08-07
SI0881901T1 (en) 2002-10-31
EE9800247A (et) 1999-02-15
BR9707556A (pt) 1999-07-27
CZ292363B6 (cs) 2003-09-17
HK1017850A1 (en) 1999-12-03
EP0881901A1 (fr) 1998-12-09
KR19990087163A (ko) 1999-12-15
DE69713287T2 (de) 2002-12-19
NO317747B1 (no) 2004-12-13
CA2246289A1 (fr) 1997-08-21
IS1892B (is) 2003-10-20
IL125848A0 (en) 1999-04-11
ES2176684T3 (es) 2002-12-01
RU2184547C2 (ru) 2002-07-10
CZ249998A3 (cs) 1998-11-11
EE03513B1 (et) 2001-10-15
EP0881901B1 (fr) 2002-06-12
DK0881901T3 (da) 2002-10-07
NO983812D0 (no) 1998-08-19
UA51695C2 (uk) 2002-12-16
NZ331444A (en) 2001-04-27
AU715655B2 (en) 2000-02-10
IS4827A (is) 1998-08-18

Similar Documents

Publication Publication Date Title
TR199801608T2 (tr) Klopidogrel ve bir tromboz önleyici içeren karisimlar
TR200000517T2 (tr) Piperidinoalkanol-Konjesyon azaltıcıdan oluşan kombinasyona yönelik farmasötik kompozisyon.
ATE324907T1 (de) Verbindung und arzneizusammensetzung zur verabreichung von wirkstoffen
ATE460921T1 (de) Medikamenthaltige zusammensetzung in aerosolform
ES2133785T3 (es) Inhibidores de metaloproteinasas.
ATE444756T1 (de) Zusammensetzungen umfassend komplexe von tocopherolphosphatderivaten
AU3955089A (en) Pharmaceutical composition comprising protein kinase c inhibitor and anti-cancer agent
GEP20012442B (en) Irreversible Inhibitors of Tyrosine Kinases
DE69531741D1 (de) Verbindungen und zusammensetzungen zur verabreichung aktiver stoffe
EE04022B1 (et) Trombiini inhibiitorite eelravimid, nende valmistamise protsess, neid sisaldav ravimpreparaat ja nende kasutamine raviks
MY112093A (en) Cosmetic delivery system for salicylic acid and process for preparation of the same.
GR3024181T3 (en) N-(alkanoylamino-2-hydroxypropyl)-sulfonamides useful as retroviral protease inhibitors.
SE8103594L (sv) N-(vinblastin-23-oyl)aminosyraderivat
ES2052603T3 (es) Derivados de bencimidazol, procedimiento para su produccion y composicion farmaceutica que los contienen.
BR9814756A (pt) Composição sólida seca para liberação de droga, processo para a preparação da mesma, uso de um grande número de pequenas esferas que contêm uma matriz polimérica composta de um polietileno glicol ou de uma mistura de polietileno glicóis
RS49703B (sr) Farmaceutske kompozicije koje sadrže vitamin d i kalcijum, njihovo dobijanje i upotreba
BR9801150A (pt) Derivados de propanolamina, processos para a preparação deles, produtos farmacêuticos compreendendo esses compostos e uso dos mesmos.
TR200100455T2 (tr) Nimesulid içeren topikal farmasötik bileşimler
ES2104133T3 (es) Composiciones cosmeticas o farmaceuticas que contienen glicerofosfolipidos desacilados para uso topico.
TR199900789T2 (tr) Oral uygulama için valproyik asit ihtiva eden farmasötik mikro-küreler.
DE4495520T1 (de) Verfahren und pharmazeutische Zusammensetzung zum zielgerichten Anwenden von Wirkstoffen
ATE293964T1 (de) Zusammensetzungen und verfahren zur behinderung der entladung von nematokyste
TR199900561T2 (tr) G-protein islevinin engellenmesi için ve çogalmaya yönelik hastaliklarin iyilestirilmesi için yararli trisiklik bilesikler.
NO20010537L (no) Farmasøytiske preparater omfattende ibuprofen og domperidon
PT86292A (pt) Processo para a preparacao de uma composicao farmaceutica anti-hipertensora,contendo um activador de canal de potassio(por exemplo,cromacalina)e um inibidor de ace(por exemplo,enalapril)